IBM faces investor doubts as quantum push meets weaker guidance

IBM is under pressure as its quantum computing claims, AI momentum and financial outlook face closer scrutiny. The stock is trading at roughly €199-203, about 31-32 percent below its 52-week high of €292.85, while its 200-day moving average sits around €226-227.

The company recently highlighted two quantum advantage demonstrations, including work with Algorithmiq on IBM Quantum Heron and a separate result with Qedma using a 74-qubit Floquet-Ising model. Critics have questioned whether IBM’s quantum messaging overstates the technology’s maturity, a concern as the company promotes a broader “quantum-centric supercomputing” strategy tied to research and university partnerships.

Investor unease grew after IBM cut its 2026 revenue growth outlook to 4-5 percent from prior guidance of growth “above 5 percent,” while keeping its free cash flow target of $15.7 billion. Susquehanna raised its price target to $235 from $225 and maintained a “Neutral” rating, citing the mainframe cycle and AI’s role in consulting signings.

IBM also has tangible growth efforts underway, including a $240 million Together AI cloud deal and a Saudi Aramco collaboration, but risks are mounting. A Singapore Land Authority breach exposed personal information of 70,000 people, some investors reduced stakes, and BFA Law is investigating potential securities fraud claims tied to new business wins and the IBM Z outlook.